Cipolle RJ, Strand ML, Morley CP. The patient-centered approach to medication management services. In: the patient-centered approach to medication management services. 3rd ed. New York: McGraw-Hill International; 2012.
Repp KL, Hayes C, Woods TM, Allen KB, Kennedy K, Borkon MA. Drug-related problems and hospital admissions in cardiac transplant recipients. Ann Pharmacother. 2012;46(10):1299–307.
van Mil F. Drug-related problems: a cornerstone for pharmaceutical care. J Malta Coll Pharm Pract. 2005;10:5–8.
van Mil JF, Westerlund LT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004;38(5):859–67.
Ayalew MB, Tegegn HG, Abdela OA. Drug related hospital admissions; a systematic review of the recent literatures. Bull Emerg Trauma. 2019;7(4):339–46.
Viktil KK, Blix HS. The impact of clinical pharmacists on drug-related problems and clinical outcomes. Basic Clin Pharmacol Toxicol. 2008;102(3):275–80.
Belayneh YM, Amberbir G, Agalu A. A prospective observational study of drug therapy-related problems in medical ward of a referral hospital in Northeast Ethiopia. BMC Health Serv Res. 2018;18(1):808.
Blix HS, Viktil KK, Moger TA, Reikvam A. Characteristics of drug-related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006;28(3):152–8.
Adisa R, Osoba DO. Evaluation of drug therapy-related problems among outpatient hypertensive and Type-2-diabetic patients at a tertiary hospital, South-West Nigeria. Niger J Pharm Res. 2020;15(2):127–41.
Gudi SK, Kashyap A, Chhabra M, Rashid M, Tiwari KK. Impact of pharmacist-led home medicines review services on drug-related problems among the elderly population: a systematic review. Epidemiol Health. 2019;41:e201e9020.
Brady A, Curtis CE, Jalal Z. Screening tools used by clinical pharmacists to identify elderly patients at risk of drug-related problems on hospital admission: a systematic review. Pharm Basel Switz. 2020;8(2):64. https://doi.org/10.3390/pharmacy8020064.
Spinewine A, Dhillon S, Mallet L, Tulkens PM, Wilmotte L, Swine C. Implementation of ward-based clinical pharmacy services in Belgium–description of the impact on a geriatric unit. Ann Pharmacother. 2006;40(4):720–8.
Viktil KK, Blix HS, Moger TA, Reikvam A. Interview of patients by pharmacists contributes significantly to the identification of drug-related problems (DRPs). Pharmacoepidemiol Drug Saf. 2006;15(9):667–74.
Gisev N, Bell JS, O’Reilly CL, Rosen A, Chen TF. An expert panel assessment of comprehensive medication reviews for clients of community mental health teams. Soc Psychiatry Psychiatr Epidemiol. 2010;45(11):1071–9.
Ewan MA, Greene RJ. Evaluation of mental health care interventions made by three community pharmacists—a pilot study. Int J Pharm Pract. 2001;9(4):225–34.
Showande SJ, Adelakun AR. Management of uncomplicated gastric ulcer in community pharmacy: a pseudo-patient study. Int J Clin Pharm. 2019;41(6):1462–70.
Collins JC, Schneider CR, Faraj R, Wilson F, de Almeida Neto AC, Moles RJ. Management of common ailments requiring referral in the pharmacy: a mystery shopping intervention study. Int J Clin Pharm. 2017;39(4):697–703.
Watson MC, Norris P, Granas AG. A systematic review of the use of simulated patients and pharmacy practice research. Int J Pharm Pract. 2006;14(2):83–93.
Björnsdottir I, Granas AG, Bradley A, Norris P. A systematic review of the use of simulated patient methodology in pharmacy practice research from 2006 to 2016. Int J Pharm Pract. 2020;28(1):13–25.
Paravattil B, Kheir N, Yousif A. Utilization of simulated patients to assess diabetes and asthma counseling practices among community pharmacists in Qatar. Int J Clin Pharm. 2017;39(4):759–68.
Driesen A, Vandenplas Y. How do pharmacists manage acute diarrhoea in an 8-month-old baby? A simulated client study. Int J Pharm Pract. 2009;17(4):215–20.
Showande SJ, Orok EN. Impact of pharmacists’ training on oral anticoagulant counseling: a randomized controlled trial. Patient Educ Couns. 2021;104(5):1253–9.
Kennelty KA, Chewning B, Wise M, Kind A, Roberts T, Kreling D. Barriers and facilitators of medication reconciliation processes for recently discharged patients from community pharmacists’ perspectives. Res Soc Adm Pharm. 2015;11(4):517–30.
Farris KB, Kirking DM. Beliefs of community pharmacists on prevention and correction of potential drug therapy-related problems. J Pharm Technol. 1996;12(5):223–30.
Ramalho-de Oliveira D, Shoemaker SJ, Ekstrand M, Alves MR. Preventing and resolving drug therapy-related problems by understanding patients’ medication experiences. J Am Pharm Assoc. 2012;52(1):71–80.
Lynn MR. Determination and quantification of content validity. Nurs Res. 1986;35(6):382–5.
Adibe MO, Igboeli NU, Ukwe CV. Evaluation of drug therapy-related problems among renal patients receiving care in some tertiary hospitals in Nigeria. Trop J Pharm Res. 2017;16(3):697–704.
Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P. Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci. 2006;28(2):61–4.
Tefera GM, Zeleke AZ, Jima YM, Kebede TM. Drug therapy-related problems and the role of clinical pharmacist in surgery Ward: prospective observational and interventional study. Drug Healthc Patient Saf. 2020;12:71–83.
Van Lint JA, Sorge LA, Sorensen TD. Access to patients’ health records for drug therapy-related problem determination by pharmacists. J Am Pharm Assoc. 2015;55(3):278–81.
Vinks THAM, de Koning FHP, de Lange TM, Egberts TCG. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci. 2006;28(1):33–8.
Westberg SM, Derr SK, Weinhandl ED, Adam TJ, Brummel AR, Lahti J, et al. Drug therapy-related problems identified by pharmacists through comprehensive medication management following hospital discharge. J Pharm Technol. 2017;33(3):96–107.
Williams M, Peterson GM, Tenni PC, Bindoff IK, Curtain C, Hughes J, et al. Drug-related problems detected in Australian community pharmacies: the PROMISe trial. Ann Pharmacother. 2011;45(9):1067–76.
Hamid AA, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78(2):202–17.
Ojeh VB, Naima N, Abah IO, Falang KD, Lucy O, London I, et al. Pattern of drug therapy-related problems and interventions in ambulatory patients receiving antiretroviral therapy in Nigeria. Pharm Pract. 2015;13(2):566.
Niriayo YL, Kumela K, Kassa TD, Angamo MT. Drug therapy-related problems and contributing factors in the management of heart failure patients in Jimma University specialized hospital, Southwest Ethiopia. PLoS One. 2018;13(10):e0206120.
Williams M, Peterson GM, Tenni PC, Bindoff IK. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems. Int J Pharm Pract. 2012;20(4):238–48.
University of Benin. Special PharmD Conversion Program. 2018. Benin City: University of Benin. Available from: http://www.unibenpharmd.net/. [cited 2021 Dec 29].
Why Nigerian varsities delay in starting PharmD degree —PCN registrar. Healthwise. 2020. Available from: https://healthwise.punchng.com/why-nigerian-varsities-delay-in-starting-pharmd-degree-pcn-registrar/. [cited 2022 Jan 3].
Obayendo T. PSN officially receives pharm. D approval letter: Pharmanewsonline; Lagos, Nigeria: 2016. Available from: https://pharmanewsonline.com/psn-officially-receives-pharm-d-approval-letter/. [cited 2022 Jan 3].
Ekpenyong A, Udoh A, Kpokiri E, Bates I. An analysis of pharmacy workforce capacity in Nigeria. J Pharm Policy Pract. 2018;11(1):20.
Update from the Registry – May 01, 2021. Pharmacists Council of Nigeria. 2021. Available from: https://www.pcn.gov.ng/update-from-the-registry-may-01-2021/. [cited 2021 Dec 29].
Bissell P, Ward P, Noyce PR. Variation within community pharmacy. 1. Responding to requests for over-the-counter medicines. J Soc Adm Pharm. 1997;14(1):1–15.
Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a “mystery shopper” study. Pharm World Sci PWS. 2002;24(4):149–53.
Watson MC, Bond CM, Grimshaw JM, Mollison J, Ludbrook A, Walker AE. Educational strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial (RCT). Fam Pract. 2002;19(5):529–36.
Kravitz RL, Epstein RM, Feldman MD, Franz CE, Azari R, Wilkes MS, et al. Influence of patients’ requests for direct-to-consumer advertised antidepressants: a randomized controlled trial. J Am Med Assoc. 2005;293(16):1995–2002.
Kelly KM, Shiau D-S, Jukkola PI, Miller ER, Mercadante AL, Quigley MM, et al. Effects of age and cortical infarction on EEG dynamic changes associated with spike wave discharges in F344 rats. Exp Neurol. 2011;232(1):15–21.
Banks J, Shaw A, Weiss MC. Walking a line between health care and sales: the role of the medicines counter assistant. Pharm J. 2005;274(7349):586–9.
Smith FJ, Salkind MR. Factors influencing the extent of the pharmacist’s advisory role in greater London. Pharm J. 1990;244(Suppl):R4–7.
Strømme HK, Haugli A. Communication and interaction between customers and pharmacy personnel in two Norwegian pharmacies—an observational study. Int J Pharm Pract. 1996;4(4):209–13.
Bates I, John C, Bruno A, Fu P, Aliabadi S. An analysis of the global pharmacy workforce capacity. Hum Resour Health. 2016;14(1):1–7.
Bates I, John C, Seegobin P, Bruno A. An analysis of the global pharmacy workforce capacity trends from 2006 to 2012. Hum Resour Health. 2018;16(1):1–9.
World Medical Association. World medical association declaration of Helsinki ethical principles for medical research involving human subjects. Clin Rev Educ. 2013;310(20):2191–4.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Disclaimer:
This article is autogenerated using RSS feeds and has not been created or edited by OA JF.
Click here for Source link (https://www.biomedcentral.com/)